AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Si-Bone Inc (NASDAQ:SIBN)
14.05 USD
+0.060 0.429%Sponsored Reports
Loading...
| Previous Close (in USD) | 13.99 |
|---|---|
| Change | +0.060 0.429% |
| 52 W H/L (in USD) | 29.510/13.340 |
| EBITDA (in USD) | -42.25M |
| PE Ratio | -- |
| Volume | 139265 |
| Diluted Eps TTM | -1.10 |
| Total Assets (in USD) | 230.425M |
|---|---|
| Total Liabilities (in USD) | 61.05M |
| Revenue TTM (in USD) | 144.045M |
| Cash (in USD) | 33.271M |
| Market Cap (in USD) | 565.330 M |
| Revenue Per Share TTM | 3.607 |
| Gross Profit TTM (in USD) | 90.704M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Si-Bone Inc
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Employees: 344
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Ms. Laura A. Francis MBA | CEO & Director | 1967 |
| 2. | Mr. Anshul Maheshwari | Chief Financial Officer | 1978 |
| 3. | Mr. Anthony J. Recupero | Pres of Commercial Operations | 1959 |
| 4. | Mr. Michael A. Pisetsky | Sr. VP of Operations & Admin., Sec. and Chief Legal Officer | 1978 |
| 5. | Mr. Jeff Bertolini | Sr. VP of Operations & Information Technology | NA |
| 6. | Dr. Scott A. Yerby | Sr. VP of Engineering & CTO | 1968 |
| 7. | Mr. Joseph W. Powers | VP of Corp. Marketing | 1960 |
| 8. | Ms. Aimee Einstein | VP of People & Culture | NA |
| 9. | Dr. Daniel Joseph Cher | Sr. VP of Clinical & Regulatory Affairs | 1965 |
| 10. | Dr. W. Carlton Reckling | Chief Medical Officer & VP of Medical Affairs | 1962 |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
+0.180 0.137% | 131.255 | 37.150 | 23.148 | 4.666 | 4.975 | 4.878 | 19.381 |
|
SYK
Stryker Corporation |
-3.200 0.871% | 365.51 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
-0.390 0.442% | 88.095 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
-1.740 1.726% | 99.94 | 68.170 | 24.570 | 5.855 | 4.265 | 6.462 | 26.799 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -61.256M | -56.572M | -43.697M | -38.403M | -17.453M |
| Minority Interest | - | - | - | - | - |
| Net Income | -62.903M | -60.128M | -48.542M | -42.576M | -17.453M |
| Selling General Administrative | 28.96M | 25.069M | 19.803M | 20.984M | 12.639M |
| Gross Profit | 90.704M | 79.724M | 64.485M | 60.511M | 50.547M |
| Reconciled Depreciation | 3.452M | 2.086M | 1.13M | 0.774M | 0.722M |
| Ebit | -59.609M | -51.67M | -38.567M | -36.003M | -12.687M |
| Ebitda | -58.437M | -51.207M | -37.596M | -33.454M | -11.965M |
| Depreciation And Amortization | 1.172M | 0.463M | 0.971M | 2.549M | 0.722M |
| Operating Income | -59.609M | -51.67M | -38.567M | -36.003M | -11.965M |
| Other Operating Expenses | 166.018M | 141.822M | 111.954M | 103.304M | 67.345M |
| Interest Expense | 2.819M | 5.365M | 6.101M | 4.949M | 5.488M |
| Tax Provision | - | - | - | - | - |
| Interest Income | 1.304M | 0.186M | 1.097M | 2.551M | 0.769M |
| Net Interest Income | -1.515M | -5.179M | -5.004M | -2.398M | -4.339M |
| Income Tax Expense | 1.647M | 3.556M | 4.845M | 4.173M | 5.488M |
| Total Revenue | 106.409M | 90.152M | 73.387M | 67.301M | 55.38M |
| Total Operating Expenses | 150.313M | 131.394M | 103.052M | 96.514M | 62.512M |
| Cost Of Revenue | 15.705M | 10.428M | 8.902M | 6.79M | 4.833M |
| Total Other Income Expense Net | -1.647M | -4.902M | -5.13M | -2.4M | -1.149M |
| Net Income From Continuing Ops | -61.256M | -56.572M | -43.697M | -38.403M | -17.453M |
| Net Income Applicable To Common Shares | -61.256M | -56.572M | -43.697M | -38.403M | -17.453M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 230.425M | 157.552M | 190.506M | 223.142M | 117.009M |
| Intangible Assets | - | - | - | - | - |
| Other Current Assets | 3.173M | 2.365M | 3.143M | 2.565M | 2.51M |
| Total Liab | 61.05M | 59.25M | 56.086M | 53.779M | 54.001M |
| Total Stockholder Equity | 169.375M | 98.302M | 134.42M | 169.363M | 63.008M |
| Other Current Liab | 17.452M | 13.511M | 1.303M | 10.199M | 0.272M |
| Common Stock | 0.004M | 455.175M | 429.917M | 408.116M | 258.124M |
| Capital Stock | 0.004M | 455.175M | 0.003M | 0.003M | 0.003M |
| Retained Earnings | -400.441M | -357.105M | -295.849M | -239.277M | -195.58M |
| Good Will | - | - | - | - | - |
| Other Assets | - | 0.375M | 0.4M | 0.374M | 0.315M |
| Cash | 33.271M | 20.717M | 63.419M | 53.581M | 10.435M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 23.456M | 21.178M | 16.89M | 13.47M | 18.774M |
| Current Deferred Revenue | - | - | 11.05M | - | 11.333M |
| Net Debt | 5.721M | 18.713M | -22.941M | -14.126M | 28.788M |
| Short Term Debt | 1.416M | 1.388M | 1.339M | - | 4.358M |
| Short Long Term Debt | - | - | - | - | 4.358M |
| Short Long Term Debt Total | 38.992M | 39.43M | 40.478M | 39.455M | 39.223M |
| Other Stockholder Equity | 569.477M | 455.172M | 429.914M | 408.113M | 258.121M |
| Property Plant Equipment | - | 15.564M | 14.24M | 4.527M | 3.954M |
| Total Current Assets | 211.394M | 137.611M | 175.866M | 218.241M | 111.462M |
| Long Term Investments | - | - | - | 0M | 1.278M |
| Short Term Investments | 132.748M | 76.573M | 83.56M | 142.851M | 81.345M |
| Net Receivables | 21.953M | 20.674M | 14.246M | 13.611M | 11.72M |
| Long Term Debt | 36.065M | 35.171M | 34.973M | 39.455M | 34.865M |
| Inventory | 20.249M | 17.282M | 11.498M | 5.633M | 5.452M |
| Accounts Payable | 4.588M | 6.279M | 3.198M | 3.271M | 2.811M |
| Accumulated Other Comprehensive Income | 0.335M | 0.232M | 0.352M | 0.524M | 0.464M |
| Non Currrent Assets Other | 0.325M | 0.375M | 0.4M | 0.374M | 0.315M |
| Non Current Assets Total | 19.031M | 19.941M | 14.64M | 4.901M | 5.547M |
| Capital Lease Obligations | 2.927M | 4.259M | 5.505M | - | - |
| Long Term Debt Total | - | 35.171M | - | 39.455M | 34.865M |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | 6.692M | 57.969M | -60.355M | 15.936M | -96.883M |
| Total Cashflows From Investing Activities | -2.815M | 51.58M | -62.916M | 13.491M | -97.825M |
| Total Cash From Financing Activities | 2.197M | -1.711M | 136.401M | 3.488M | 115.15M |
| Net Income | -61.256M | -56.572M | -43.697M | -38.403M | -17.453M |
| Change In Cash | -42.702M | 9.838M | 43.146M | -14.685M | 2.712M |
| Begin Period Cash Flow | 63.419M | 53.581M | 10.435M | 25.12M | 22.408M |
| End Period Cash Flow | 20.717M | 63.419M | 53.581M | 10.435M | 25.12M |
| Total Cash From Operating Activities | -41.655M | -39.533M | -30.662M | -31.627M | -14.519M |
| Depreciation | 3.452M | 2.086M | 1.13M | 0.774M | 0.722M |
| Other Cashflows From Investing Activities | - | - | - | 15.936M | -96.883M |
| Dividends Paid | - | - | -1.915M | - | - |
| Change To Inventory | -5.709M | -5.784M | -0.274M | -2.105M | -0.759M |
| Sale Purchase Of Stock | 1.818M | 2.343M | 1.915M | 2.203M | -0.073M |
| Other Cashflows From Financing Activities | -2.815M | 36.946M | 47.082M | 1.285M | -0.283M |
| Capital Expenditures | 9.507M | 6.389M | 2.561M | 2.445M | 0.942M |
| Change In Working Capital | -7.642M | -5.756M | -2.527M | -0.479M | -1.023M |
| Other Non Cash Items | 0.73M | 0.288M | 0.292M | 0.259M | 0.259M |
| Free Cash Flow | -51.162M | -45.922M | -33.223M | -34.072M | -15.461M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Champlain Small Company Fund, LLC | 10 months ago | 1842633 |
| 2. | Worldwide Healthcare Ord | 1 year ago | 1502031 |
| 3. | American Century Small Cap Growth Inv | 11 months ago | 1421747 |
| 4. | American Century U.S. Small Cap Growth | 11 months ago | 1421747 |
| 5. | Brown Advisory Small-Cap Growth Inv | 11 months ago | 1285006 |
| 6. | Vanguard Total Stock Mkt Idx Inv | 10 months ago | 1187253 |
| 7. | iShares Russell 2000 ETF | 10 months ago | 934397 |
| 8. | CREF Stock R1 | 11 months ago | 563946 |
| 9. | Vanguard Institutional Extnd Mkt Idx Tr | 10 months ago | 561674 |
| 10. | JNL Multi-Manager Small Cap Growth A | 11 months ago | 555443 |
| 11. | Champlain Small Company Adv | 1 year ago | 490000 |
| 12. | Impax US Small Cap Strategy Composite | 11 months ago | 475343 |
| 13. | Impax Small Cap Institutional | 1 year ago | 475343 |
| 14. | Principal SmallCap Growth I Instl | 10 months ago | 470765 |
| 15. | Brown Advisory US SmlrComs Dollar B Acc | 10 months ago | 443757 |
| 16. | Fidelity Small Cap Index | 1 year ago | 406141 |
| 17. | Invesco Main Street Small Cap R6 | 11 months ago | 357155 |
| 18. | Invesco Small Cap Core | 11 months ago | 357155 |
| 19. | Old Westbury Small & Mid Cap Strategies | 1 year ago | 334990 |
| 20. | iShares Russell 2000 Growth ETF | 10 months ago | 333132 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Dimensional Fund Advisors, Inc. | 11 months ago | 664506 |
| 2. | Holocene Advisors, LP | 11 months ago | 585311 |
| 3. | Victory Capital Management Inc. | 11 months ago | 576677 |
| 4. | Brown Advisory Holdings Inc | 11 months ago | 4223342 |
| 5. | BlackRock Inc | 1 year ago | 3907197 |
| 6. | Orbimed Advisors, LLC | 11 months ago | 3174521 |
| 7. | First Light Asset Management, LLC | 11 months ago | 2473165 |
| 8. | Vanguard Group Inc | 11 months ago | 2463501 |
| 9. | Champlain Investment Partners, LLC | 11 months ago | 2453147 |
| 10. | American Century Companies Inc | 11 months ago | 1617839 |
| 11. | Granahan Investment Management Inc.. | 11 months ago | 1592574 |
| 12. | Bellevue Group AG | 11 months ago | 1139956 |
| 13. | Paradigm Capital Management, Inc. | 11 months ago | 1082300 |
| 14. | Next Century Growth Investors LLC | 11 months ago | 1070166 |
| 15. | Silvercrest Asset Management Group LLC | 11 months ago | 1060937 |
| 16. | Morgan Stanley - Brokerage Accounts | 1 year ago | 1033328 |
| 17. | State Street Corporation | 1 year ago | 971317 |
| 18. | Nuveen Asset Management, LLC | 1 year ago | 945713 |
| 19. | Geode Capital Management, LLC | 1 year ago | 826859 |
| 20. | Wellington Management Company LLP | 1 year ago | 817048 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Related Articles
Loading...
